What is BTAIQ's dilution risk score?

BTAIQ has a latest available DilutionScore record of 74/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BTAIQ, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BTAIQ?

DilutionWatch tracks 25 SEC filing types for BTAIQ including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BTAIQ shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BTAIQ, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BTAIQ tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BTAIQ. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 8,500+ active tickers monitored.

BTAIQ Dilution Risk Score: 74/100

Score Breakdown

📋 Offering Ability

💰 Cash Runway

📊Float Risk—

⚠️ Warrant Exposure

🔄 Convertible Debt

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 41%

💰 Capital Raise model 55%

• Critical: only 1.6 months cash remaining

📜 Warrant Exercise model 40%

• Significant warrants: 25% of shares outstanding

• Elevated warrant risk score (70/100)

📉 Score Deterioration model 10%

• Score in HIGH risk zone (74/100)

🔔 Track BTAIQ — Get forecast alerts →

Market Data

Market Cap$438.3K

Shares Outstanding31.31M

FloatN/A

Cash$12.84M

Debt$104.45M

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	74/100	DilutionWatch score record
Shares Outstanding	31.31M	Verified float table or market cache
Public Float	Not available	Verified float table or market cache
Market Cap	$438.3K	Market data cache
Cash Runway	1.6 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	7.86M	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 3 1, 4 1, SC 13G/A 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest1.64M

Days to Cover3.7

% of FloatN/A

FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13

4 INSIDER TRANSACTION 2026-08-14

3 FORM3 2026-08-14

SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14

Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BTAIQ Dilution Snapshot

BioXcel Therapeutics, Inc. (BTAIQ) has a DilutionScore of 74/100, rated High dilution risk. Score date: October 28, 2026.

Stored outstanding warrants: 7.9M.
Recent SEC activity tracked for BTAIQ: 4 on 2026-08-14; 3 on 2026-08-14; SC 13G/A on 2026-08-14.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BTAIQ's DilutionScore is currently 74/100 (High risk), with 1 score change tracked over 90 days. The score improved from 40/100 (Medium risk).

Period	Score	Risk Level	Duration
Sep 18 – Oct 28, 2026	74/100	HIGH	41 days
Jul 31 – Sep 17, 2026	40/100	MEDIUM	49 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track BTAIQ Dilution Risk in Real-Time

DilutionWatch monitors SEC filings 24/7 and alerts you the moment BTAIQ files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.

Start Tracking BTAIQ — Free

Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,567+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

BTAIQ — BioXcel Therapeutics, Inc. Dilution Risk Tracker